NUVB:NYSENuvation Bio Inc. analysis
Data as of Sep 18, 2026 - not real-time
- Latest price
- $5.85
- Risk: high
- 9/10High risk
Summary
The moving-average structure behind Nuvation Bio Inc. is bullish at $5.85, with short-term averages leading the long-term ones. Over a rolling month the price has lost 4.3%. With RSI at 39.1 the momentum picture is approaching oversold, alongside a bearish MACD signal. Watch $5.63 as support and $7.18 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 123.9% above the current price. Revenue is growing at 555.6% on a -88.2% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 58.5%, a beta of 1.72 and a maximum drawdown of 57.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 123.9% above the current price. Revenue is growing at 555.6% on a -88.2% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 58.5%, a beta of 1.72 and a maximum drawdown of 57.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.
Top market events
- Nuvation Bio NUVB delivered earnings and revenue surprises of 0.
- Nuvation Bio NUVB might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade...
- Nuvation Bio NUVB was a big mover last session on higher-than-average trading volume.
Market outlook
Short term
< 1 yearNeutral
Model confidence2/102 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- Trading below the 200-day average of 5.90
- MACD momentum is negative
Medium term
1–3 yearsNeutral
Model confidence2/102 out of 10
Key factors
- Short-term moving averages stacked above long-term ones
- Trading below the 200-day average of 5.90
- Analyst targets imply +123.9% versus the current price
Long term
> 3 yearsNeutral
Model confidence3/103 out of 10
Key factors
- Negative profit margin of -88.2%
- Analyst targets imply +123.9% versus the current price
- Negative return on equity of -47.8%
Key metrics
Financial health
Revenue Growth555.60%
Profit Margin-88.19%
P/E Ratio-390.0
ROE-47.81%
ROA-12.36%
Debt/Equity163.97
P/B Ratio8.1
Op. Cash Flow$-120522000
Free Cash Flow$-112112496
Industry P/E30.1
Technical analysis
TrendBullish
RSI39.1
Support$5.63
Resistance$7.18
MA 20$6.51
MA 50$6.42
MA 200$5.90
MACDBearish
VolumeIncreasing
Fear & Greed Index94.98
Valuation
Target Price$13.10
Upside/Downside123.93%
GradeFair
TypeGrowth
Risk assessment
Beta1.72
Volatility58.47%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.